Literature DB >> 22284782

Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs.

Nitika Pant Pai1, Madhukar Pai.   

Abstract

Early diagnosis and rapid initiation of treatment remains a key strategy to control both HIV and tuberculosis (TB). However, HIV and TB control programs have had completely contrasting successes, especially with the development and deployment of point-of-care (POC) diagnostics. Clinicians, researchers, and public health staff who work at the frontlines of HIV care and control have had access to an outstanding array of POC diagnostics at their disposal, including those used for screening, initial diagnosis, staging, treatment monitoring, and early infant diagnosis. The field has also advanced to consider over-the-counter, self-testing options for HIV and the use of multiplexed platforms that allow for simultaneous detection of infections associated with HIV. In sharp contrast to HIV, suboptimal and delayed diagnosis of TB has perpetuated the epidemic in many high-burden countries. Although the TB diagnostics pipeline is substantially better today than it was even five years ago, absence of a simple POC test continues to be a gaping hole in the pipeline. In this review, we compare the POC diagnostics landscape and pipelines for these two important infectious diseases, and highlight gaps and unmet needs.

Entities:  

Mesh:

Year:  2012        PMID: 22284782

Source DB:  PubMed          Journal:  Discov Med        ISSN: 1539-6509            Impact factor:   2.970


  33 in total

Review 1.  Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.

Authors:  Maunank Shah; Colleen Hanrahan; Zhuo Yu Wang; Nandini Dendukuri; Stephen D Lawn; Claudia M Denkinger; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2016-05-10

Review 2.  Economic challenges associated with tuberculosis diagnostic development.

Authors:  Colleen F Hanrahan; Maunank Shah
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2014-04-28       Impact factor: 2.217

Review 3.  Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV.

Authors:  Stephanie Bjerrum; Ian Schiller; Nandini Dendukuri; Mikashmi Kohli; Ruvandhi R Nathavitharana; Alice A Zwerling; Claudia M Denkinger; Karen R Steingart; Maunank Shah
Journal:  Cochrane Database Syst Rev       Date:  2019-10-21

Review 4.  Existing and Emerging Technologies for Point-of-Care Testing.

Authors:  Andrew St John; Christopher P Price
Journal:  Clin Biochem Rev       Date:  2014-08

Review 5.  Implementing HIV-1 genotypic resistance testing in antiretroviral therapy programs in Africa: needs, opportunities, and challenges.

Authors:  Richard J Lessells; Ava Avalos; Tulio de Oliveira
Journal:  AIDS Rev       Date:  2013 Oct-Dec       Impact factor: 2.500

Review 6.  Nucleic acid testing for tuberculosis at the point-of-care in high-burden countries.

Authors:  Angelika Niemz; David S Boyle
Journal:  Expert Rev Mol Diagn       Date:  2012-09       Impact factor: 5.225

Review 7.  Point-of-care assays for tuberculosis: role of nanotechnology/microfluidics.

Authors:  ShuQi Wang; Fatih Inci; Gennaro De Libero; Amit Singhal; Utkan Demirci
Journal:  Biotechnol Adv       Date:  2013-01-26       Impact factor: 14.227

8.  Can combination prevention strategies reduce HIV transmission in generalized epidemic settings in Africa? The HPTN 071 (PopART) study plan in South Africa and Zambia.

Authors:  Sten H Vermund; Sarah J Fidler; Helen Ayles; Nulda Beyers; Richard J Hayes
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07       Impact factor: 3.731

Review 9.  p24 revisited: a landscape review of antigen detection for early HIV diagnosis.

Authors:  Eleanor R Gray; Robert Bain; Olivia Varsaneux; Rosanna W Peeling; Molly M Stevens; Rachel A McKendry
Journal:  AIDS       Date:  2018-09-24       Impact factor: 4.177

10.  Detection of Mycobacterium tuberculosis GlcB or HspX Antigens or devR DNA impacts the rapid diagnosis of tuberculous meningitis in children.

Authors:  Sagarika Haldar; Naveen Sankhyan; Neera Sharma; Anjali Bansal; Vitul Jain; V K Gupta; Monica Juneja; Devendra Mishra; Arti Kapil; Urvashi B Singh; Sheffali Gulati; Veena Kalra; Jaya Sivaswami Tyagi
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.